Presentation of Results for the year ended 30 June 2025 Niël Pretorius Chief Executive Officer Riaan Davel Chief Financial Officer Results for the year ended 30 June 2025 | Page 1 DISCLAIMER 18th consecutive financial year of dividends: Final cash dividend of 40 cps | Financial | | Operational | | Sustainable development | | | --- | --- | --- | --- | --- | --- | | Revenue R7 878.2m | Operating profit R3 523.6m | Production 4 830kg | All-in sustaining costs margin | Electricity consumption 282 560MWh | Potab ...

NEX T BI OM ET RI CS GR OU P ASA Q2 Presentation Aug ust 20, 2025 Disclaimer This presentation includes and is based, inter alia, on forward-looking information and statements that are subject to risks and uncertainties that could cause actual results to differ. Such forward-looking information and statements are based on current expectations, estimates and projections about global economic conditions, the economic conditions of the regions and industries that are major markets for NEXT Biometrics Group ASA ...

Financial Performance - Operating profit reached $159.7 million, a 5.4% increase compared to FY24[8,18] - Operating EPS increased by 7.3% to 89.8 cents[8,18] - The full year dividend increased by 12.6% to 73.3 cents per share[8,18] - Returns to shareholders totaled $202.1 million, a 64% increase from FY24, including $74 million from on-market share buy-backs and $128 million in total dividends[8,18,19] - Strategic partnership income surged by 202% year-over-year to $31.1 million, representing 20% of total operating profit[8,10] - Fund investment income increased by 210% to $42.2 million[20] Assets Under Management (AUM) - Assets under management (AUM) grew by 8.2% year-over-year, reaching $39.6 billion[8,10,18] - Investment Management revenue decreased by 12% year-over-year to $245.7 million, due to a decline in margins[8,10,18] Strategic Partnerships - Invested capital in strategic partnerships increased by 103% to $324.5 million[24] - Strategic partnerships returned 10% on invested capital in FY25, up 4% over the year[26] - FinClear reported revenue growth of 8% year-on-year and underlying EBITDA growth of 15% year-on-year[62,63]

Financial Performance - Group revenue reached $430.5 million, an increase of 8.2% compared to FY24[9, 26] - Group EBITDA amounted to $43.2 million, up 9.1% from FY24, exceeding the guidance range of $42 million to $43 million[9, 26] - NPATA increased by 11.4% to $10.2 million compared to FY24[26] - A final dividend of 9.0 cents fully franked was declared for FY25, bringing the total dividends for the year to 14.0 cents, representing a dividend yield of 7.8% based on the 30-day VWAP[10, 26] Segment Performance - Australia's revenue grew by 6.4% to $350.6 million, with EBITDA at $33.5 million and a margin of 9.6%, reflecting an 8.1% increase in EBITDA and a 20bp margin improvement[9, 13] - China's revenue increased by 18.3% to $101.0 million, with EBITDA at $9.7 million and a margin of 9.6%, representing a 12.7% increase in EBITDA but a 50bp margin contraction[10, 18] - Tulip revenue in China increased by approximately 40%, driven by both volume and ASP growth, while export volume and revenue rose by about 25%[20] Cash Flow and Capital Expenditure - Cash conversion stood at 96%, with a seasonal unwind of working capital achieved in the second half of the year[26, 44] - Capital expenditure for FY25 totaled $7.2 million, including $3.9 million in growth CAPEX and $3.2 million in maintenance CAPEX[46, 47] - Net debt to EBITDA ratio decreased to 1.5x from 1.7x in June 2024[52] Outlook - Revenue for the first seven weeks of FY26 is up 5% in Australia and down 14% in China compared to the same period in FY25[56, 58] - FY26 revenue growth is expected in both Australia and China, with Australia's margin rate anticipated to be in line with FY25[60]

Company Overview - ZTO is a leading express delivery company in China, holding the 1 market share by parcel volume since 2016[12] - In 2Q25, ZTO delivered 98 billion parcels, capturing a 195% market share[12] - ZTO's network covers >99% of county-level cities in China[12] Competitive Advantages - ZTO operates 94 sorting hubs and has deployed 690 automation lines[12,69] - The company has a self-owned line-haul fleet of over 10,000 vehicles and operates approximately 3,900 line-haul routes[12] - ZTO's Network Partner Model (NPM) has increased its market share from 66% in 2011 to 73% in 2024, compared to the Direct Model[21] Financial Performance (Q2 2025) - ZTO's quarterly revenue reached RMB 11832 million, representing a 10% year-over-year growth[157] - The company's adjusted EBITDA margin was 299%[161] - Adjusted Net Income margin was 173%[166] ESG Initiatives - The company aims for a 20% reduction in GHG emissions intensity per parcel by 2028, using 2023 as the base year[120] - ZTO is increasing the proportion of women in management positions to 39% by 2030[123] - The company is actively involved in community and rural revitalization programs[123]

Financial Performance - Revenue increased by 253% to $1521 million compared to PCP[15], and by 66% compared to the prior half[15] - Underlying profit before tax decreased by 3% to $139 million compared to PCP[15][16] - Underlying EBITDA was broadly flat at $269 million compared to PCP, but margins compressed to 177%[15][16] Segment Performance - North America revenue was broadly flat compared to the prior half on a constant currency basis[40] - Latin America revenue increased by 8% compared to PCP, but decreased by 16% compared to the prior half[48] - Asia Pacific revenue increased significantly by 812% to $346 million compared to PCP and by 466% compared to the prior half[52] - Online segment revenue decreased, with segment profit dropping significantly[53] Operational Highlights - Gaming operations units totaled 6,649, a reduction from 6,871 at the end of December 2024[16] - Recurring revenue from gaming operations contributed $507 million, compared to $489 million in PCP[16] - The A-Star Raptor dual screen cabinet launched in February 2025 was well received in Asia Pacific[80] Balance Sheet and Cash Flow - Net cash position reduced to $14 million at 30 June 2025, compared to $97 million at 31 December 2024[16] - Net cash used in operating activities was $47 million, primarily due to increased investment in inventory[37]

Financial Performance Highlights - APA Group's FY25 Distribution Per Security (DPS) was 570 cents, aligning with guidance[32] - Underlying EBITDA reached $2015 million, reflecting a 64% increase excluding the Pilbara Energy System[32] - Free Cash Flow (FCF) amounted to $1083 million, marking a 09% rise[36] - The Underlying EBITDA margin improved by 09 percentage points to 742%[35] Future Guidance - FY26 Underlying EBITDA guidance is set between $2120 million and $2200 million, indicating a 72% increase at the midpoint[35] - FY26 DPS guidance is projected at 580 cents, a 1 cent increase from FY25[35] Strategic Initiatives - APA Group is targeting approximately $50 million uplift in Underlying EBITDA in FY26 from cost reduction initiatives[40] - The company has an organic growth pipeline of approximately $21 billion for FY26-FY28, funded by balance sheet capacity and the Distribution Reinvestment Plan (DRP)[40] Sustainability - APA Group achieved a 65% gross and 133% net reduction in FY25 gas infrastructure emissions compared to the FY21 base year[38]

CORPORATE UPDATE INVESTOR CALL – 20 August 2025 Dr Jeremy Levin – Chairman of the Board Fred Guerard – Chief Executive Officer Tom Reilly – Chief Financial Officer For personal use only Important Information This investor presentation (Presentation) is dated August 19th, 2025 and has been prepared by Opthea Limited (ASX:OTP) (Opthea or the Company). SUMMARY INFORMATION This Presentation is for information purposes only and is not a prospectus, disclosure document, product disclosure statement or other offer ...

Clinical Trial Updates - Azer-cel showed a 79% best overall response rate in a Phase 1b trial (N=14)[8, 10] - A 57% overall response/complete response rate was achieved in February 2025 for azer-cel[13] - The company anticipates initiating a pivotal Phase 2/3 registrational trial for azer-cel in CY2026, pending data and regulatory approvals[8] - onCARlytics Phase 1 OASIS trial is currently in Phase 1 in solid cancers in combination with Blinatumomab, showing early results in bile tract cancer and durable stability of disease[8] - VAXINIA received Orphan Drug Designation in September 2024[14] Business and Financial Strategy - The company is out-licensing azer-cel Phase 1b product to Kincell to offset costs and headcount[9] - Cost-cutting measures are ongoing, including headcount reductions and prioritizing programs for value-impacting studies[9] - The company is actively seeking partnering/out-licensing opportunities[9, 14] Upcoming Milestones - Additional Phase 1b azer-cel data is expected to be released in Q3 CY25 and Q4 CY25[14, 16] - An FDA meeting is planned for azer-cel to discuss registrational strategy/pivotal study[8, 16] - The company plans to initiate activity for a registrational/pivotal study for azer-cel[16]

Q1 FY26 Financial Performance - Net sales reached $900 million, a decrease of 9% compared to the prior year[34] - Adjusted EBITDA was $226 million, down 21% year-over-year, with an Adjusted EBITDA Margin of 251%, a decrease of 370 basis points[16, 34] - Adjusted diluted EPS was $029, a 28% decrease[34] - Free cash flow increased by 88% to $104 million[34] AZEK Acquisition and Integration - AZEK Residential quarterly net sales were $417 million with Adjusted EBITDA of $127 million and Adjusted EBITDA Margin of 304%[18] - The company reaffirms expectation to exit FY26 annualizing a third of total cost synergies, representing approximately $20 million of actual anticipated P&L benefit within FY26, concentrated in 2H FY26[27] - The company is on track to achieve $125 million in cost synergies and anticipates over $500 million in commercial synergies[26] FY26 Financial Guidance - The company issues new FY26 guidance reflecting contribution from AZEK[30] - FY26 Siding & Trim net sales are projected to be $2675 to $285 billion[51] - FY26 Deck, Rail & Accessories net sales are projected to be $775 to $800 million[51] - AZEK contribution to Adjusted EBITDA is expected to be +$250 to $265 million, with total Adjusted EBITDA between $105 to $115 billion[51] - Free cash flow is expected to be $200 million+, including approximately $315 million of incremental interest expense and transaction & integration costs related to the AZEK acquisition[51, 53]